MONTIVIB LC (15 PACK) MONTELUKAST SODIUM 10mg. IP + LEVOCETIRIZINE 5mg. IP

Montivib LC (15 Pack) gives Montelukast 10 mg plus Levocetirizine 5 mg for asthma prevention and relief of itching and hives. Main uses: long-term prevention and control of asthma symptoms in adults and adolescents; prevention of breathing difficulty triggered by exercise; relief of symptoms of seasonal allergic rhinitis such as sneezing and a runny or blocked nose, reserved for patients who do not respond to or cannot take other treatments, because montelukast carries a risk of serious neuropsychiatric events; relief of symptoms of perennial allergic rhinitis under the same reserve-use limitation; relief of the itching and hives of chronic idiopathic urticaria in adults and children 6 years and older.

Common side effects of Montivib LC Tablet include headache; drowsiness or somnolence; dry mouth; tiredness or fatigue; upper respiratory infection; sore throat. Get medical help at once if you notice serious neuropsychiatric events such as agitation, aggression, depression, sleep disturbances and suicidal thoughts or behaviour; severe allergic reactions including swelling of the face or lips and anaphylaxis; urinary retention.

Each Montivib LC tablet contains Montelukast Sodium 10 mg + Levocetirizine 5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Montivib LC Tablet only as your doctor advises.

The MRP of Montivib LC Tablet is ₹245 for a pack of 10x15 (Alu Alu). For chemists and distributors, the PTR is ₹186.67 and the PTS is ₹168.

Each Montivib LC tablet contains Montelukast Sodium 10 mg + Levocetirizine 5 mg. It comes in a pack of 10x15 (Alu Alu).

The tablet works through two separate actions. Montelukast Sodium blocks leukotriene receptors in the airways and nose, helping reduce swelling, mucus and tightening of the air passages. Levocetirizine blocks histamine at H1 receptors, which eases sneezing, watery eyes, itching and hives. Because each ingredient works on a different part of the allergic response, the tablet covers both pathways.

Must not be used by anyone allergic to montelukast, levocetirizine, cetirizine or any other ingredient of the tablet. Must not be used by patients with end-stage kidney disease (creatinine clearance below 10 mL/min) or patients on haemodialysis. Must not be used to treat a sudden asthma attack; an appropriate rescue medicine should be kept at hand. Check with a doctor first if you have kidney problems, are pregnant or breastfeeding, or have a condition that can cause urinary retention. Check with a doctor first before driving or operating machinery, and avoid alcohol, since drowsiness can occur.

Montivib LC Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.